Sales up 15%, in line with targets of the year
The past year has been characterized by a slight and uneven economic recovery in the global context, producing greater growth in Asian and Latin American economies than in the European or North American economic systems.
In this global macroeconomic environment, Vircell has achieved an absolute increase of turnover, exceeding 15% with respect to the year 2011. This year, international sales have increased their contribution to total revenues, representing 73% of the total sales in 2012. (Graph1)
In this period, our international network of distributors has been expanded by succeeding in making an entrance to new markets in North America, Asia and Eastern Europe, and consolidating the sales in key destinations for the growth strategy of Vircell. These efforts have brought about to maintain a diversified mix of sales, with Europe (46%), Asia (27%) and America (16%) as the main markets. (Graph 2)
Sales by product structure remain similar to previous years; ELISA was the best selling product line accounting for 47% of the business, followed closely by IFA with 36% of the sales (Graph 3). We must highlight the important increase in the turnover of AmpliRun® Amplification Controls which has also expanded the references panel during 2012.
The excellent results achieved in 2012 are indicative of the professionalism of our distributors and the dedication, effort and know-how of our employees, who work to provide the best diagnostic solutions to our customers in all the markets.
Quoting the words of Vircell’s CEO, Dr. Joaquín Mendoza: "In 2013 we have planned the move to our new facilities in the Health Technology Park of Granada (PTS, its acronym in Spanish). The new building, which has meant the investment of more than 7 million euros, extends and enhances the existing facilities and will help Vircell to meet current and future business needs. The development of new products will continue to be a mainstay in our company and in many cases, our most important distinguishing feature. This year we will focus our efforts on reaching new markets in the Asia-Pacific area, and enhance the penetration of new references in strategic markets”